This new $100M fund plans to focus on startups accelerating the science around longevity

2017-08-24_00h03_35 IT総合
Longevity-focused startups have been proliferating in recent years as we become more focused on our health. However, it’s not just about apps to get you in the gym. Longevity startups can range from biotech-oriented disease prevention, even to organ regeneration. The Aging Analytics Agency estimates that global investments in longevity-focused startups hit more than $40bn in 2021, and the market could grow to $600bn by 2025, according to Bank of America.
Now investors like Apollo Health are raising large sums – such as their $180m fund in November, while Maximon, Swiss longevity company